138 related articles for article (PubMed ID: 35456876)
1.
Satomi S; Kokubu D; Inoue T; Sugiyama M; Mizokami M; Suzuki S; Murata K
Microorganisms; 2022 Apr; 10(4):. PubMed ID: 35456876
[TBL] [Abstract][Full Text] [Related]
2. Identification and Safety Assessment of
Satomi S; Takahashi S; Inoue T; Taniguchi M; Sugi M; Natsume M; Suzuki S
Microorganisms; 2024 May; 12(5):. PubMed ID: 38792783
[TBL] [Abstract][Full Text] [Related]
3. IFN-Lambda 3 Mediates Antiviral Protection Against Porcine Epidemic Diarrhea Virus by Inducing a Distinct Antiviral Transcript Profile in Porcine Intestinal Epithelia.
Li L; Xue M; Fu F; Yin L; Feng L; Liu P
Front Immunol; 2019; 10():2394. PubMed ID: 31681286
[TBL] [Abstract][Full Text] [Related]
4. Genetic Polymorphisms within Interferon-λ Region and Interferon-λ3 in the Human Pathophysiology: Their Contribution to Outcome, Treatment, and Prevention of Infections with Hepatotropic Viruses.
Grzegorzewska AE
Curr Med Chem; 2019; 26(25):4832-4851. PubMed ID: 30027841
[TBL] [Abstract][Full Text] [Related]
5. Lambda-Interferons Inhibit Herpes Simplex Virus Type 2 Replication in Human Cervical Epithelial Cells by Activating the JAK/STAT Pathway.
Li Z; Lu X; Zhu Y; Cheng P; Liu S; Zhang Y; Tang J; Yang S; Zhou L
Jpn J Infect Dis; 2017 Jul; 70(4):416-422. PubMed ID: 28250263
[TBL] [Abstract][Full Text] [Related]
6. Antiviral and antiproliferative effects of canine interferon-λ1.
Ichihashi T; Asano A; Usui T; Takeuchi T; Watanabe Y; Yamano Y
Vet Immunol Immunopathol; 2013 Nov; 156(1-2):141-6. PubMed ID: 24126210
[TBL] [Abstract][Full Text] [Related]
7. A novel method for detection of IFN-lambda 3 binding to cells for quantifying IFN-lambda receptor expression.
Santer DM; Minty GES; Mohamed A; Baldwin L; Bhat R; Joyce M; Egli A; Tyrrell DLJ; Houghton M
J Immunol Methods; 2017 Jun; 445():15-22. PubMed ID: 28274837
[TBL] [Abstract][Full Text] [Related]
8. Interferon-λ3 Exacerbates the Inflammatory Response to Microbial Ligands: Implications for SARS-CoV-2 Pathogenesis.
Read SA; Gloss BS; Liddle C; George J; Ahlenstiel G
J Inflamm Res; 2021; 14():1257-1270. PubMed ID: 33833547
[TBL] [Abstract][Full Text] [Related]
9. mRNA expression of IFN-λs in the gingival tissue of patients with chronic or aggressive periodontitis: A polymerase chain reaction study.
Bilichodmath S; Nair SK; Bilichodmath R; Mangalekar SB
J Periodontol; 2018 Jul; 89(7):867-874. PubMed ID: 29717481
[TBL] [Abstract][Full Text] [Related]
10. Interferon-lambda3 (IFN-λ3) and its cognate receptor subunits in tree shrews (Tupaia belangeri): genomic sequence retrieval, molecular identification and expression analysis.
Li ML; Xu WW; Gao YD; Guo Y; Wang WJ; Wang C; Jiang SY; Willden A; Huang JF; Zhang HT
PLoS One; 2013; 8(3):e60048. PubMed ID: 23555878
[TBL] [Abstract][Full Text] [Related]
11. Murine interferon lambdas (type III interferons) exhibit potent antiviral activity in vivo in a poxvirus infection model.
Bartlett NW; Buttigieg K; Kotenko SV; Smith GL
J Gen Virol; 2005 Jun; 86(Pt 6):1589-1596. PubMed ID: 15914836
[TBL] [Abstract][Full Text] [Related]
12. Comparative Transcriptomic and Proteomic Analyses Prove that IFN-λ1 is a More Potent Inducer of ISGs than IFN-α against Porcine Epidemic Diarrhea Virus in Porcine Intestinal Epithelial Cells.
Zhao M; Li L; Zhai L; Yue Q; Liu H; Ren S; Jiang X; Gao F; Bai S; Li H; Zhang Y; Xu H; Zhang L; Liu P; Tan M; Yu Q
J Proteome Res; 2020 Sep; 19(9):3697-3707. PubMed ID: 32692179
[TBL] [Abstract][Full Text] [Related]
13. IL-28B (IFN-λ3) and IFN-α synergistically inhibit HCV replication.
Shindo H; Maekawa S; Komase K; Miura M; Kadokura M; Sueki R; Komatsu N; Shindo K; Amemiya F; Nakayama Y; Inoue T; Sakamoto M; Yamashita A; Moriishi K; Enomoto N
J Viral Hepat; 2013 Apr; 20(4):281-9. PubMed ID: 23490373
[TBL] [Abstract][Full Text] [Related]
14. Human blood dendritic cell antigen 3 (BDCA3)(+) dendritic cells are a potent producer of interferon-λ in response to hepatitis C virus.
Yoshio S; Kanto T; Kuroda S; Matsubara T; Higashitani K; Kakita N; Ishida H; Hiramatsu N; Nagano H; Sugiyama M; Murata K; Fukuhara T; Matsuura Y; Hayashi N; Mizokami M; Takehara T
Hepatology; 2013 May; 57(5):1705-15. PubMed ID: 23213063
[TBL] [Abstract][Full Text] [Related]
15. Activation of type III interferon genes by pathogenic bacteria in infected epithelial cells and mouse placenta.
Bierne H; Travier L; Mahlakõiv T; Tailleux L; Subtil A; Lebreton A; Paliwal A; Gicquel B; Staeheli P; Lecuit M; Cossart P
PLoS One; 2012; 7(6):e39080. PubMed ID: 22720036
[TBL] [Abstract][Full Text] [Related]
16. Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo.
Ank N; West H; Bartholdy C; Eriksson K; Thomsen AR; Paludan SR
J Virol; 2006 May; 80(9):4501-9. PubMed ID: 16611910
[TBL] [Abstract][Full Text] [Related]
17. Interferon lambda induces antiviral response to herpes simplex virus 1 infection.
Lopušná K; Režuchová I; Kabát P; Kúdelová M
Acta Virol; 2014; 58(4):325-32. PubMed ID: 25518713
[TBL] [Abstract][Full Text] [Related]
18. Interferon-λ3 Promotes Epithelial Defense and Barrier Function Against Cryptosporidium parvum Infection.
Ferguson SH; Foster DM; Sherry B; Magness ST; Nielsen DM; Gookin JL
Cell Mol Gastroenterol Hepatol; 2019; 8(1):1-20. PubMed ID: 30849550
[TBL] [Abstract][Full Text] [Related]
19. Integrative genomic analyses on interferon-lambdas and their roles in cancer prediction.
Yang L; Wei J; He S
Int J Mol Med; 2010 Feb; 25(2):299-304. PubMed ID: 20043142
[TBL] [Abstract][Full Text] [Related]
20. Type III Interferons in Hepatitis C Virus Infection.
Boisvert M; Shoukry NH
Front Immunol; 2016; 7():628. PubMed ID: 28066437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
